Prof. Dr. Kayhan Ertürk

Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study

BMC Cancer, 2026

DOI 10.1186/s12885-026-15725-9 PMID 41691201 Açık erişimli tam metinKaynak: OpenAlex

Perioperative FLOT versus Definitive 50.4 Gy Chemoradiotherapy in Siewert II Esophagogastric Junction Adenocarcinoma: A Multicenter Retrospective Cohort Study

Cancer Management and Research, 2026

DOI 10.2147/cmar.s583473 PMID 42038552 Açık erişimli tam metinKaynak: OpenAlex

Prognostic factors and survival outcomes in older adults with extensive-stage small cell lung cancer: A multicenter retrospective cohort study

Medicine, 2026

DOI 10.1097/md.0000000000048711 PMID 42116366 Açık erişimli tam metinKaynak: OpenAlex

Prognostic value of PSMA PET–derived tumor volume in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide

Cancer Imaging, 2026

DOI 10.1186/s40644-026-01036-6 PMID 42063136 Açık erişimli tam metinKaynak: OpenAlex

Neoadjuvant anthracycline-free versus anthracycline-containing chemotherapy combined with dual HER2 blockade in HER2-positive breast cancer: a real-world comparative study

Breast Cancer Research, 2026

DOI 10.1186/s13058-026-02312-w PMID 42210329 Açık erişimli tam metinKaynak: OpenAlex

Efficacy and tolerability of CDK 4/6 inhibitors in HR-positive HER2-negative de novo metastatic breast cancer patients aged ≥ 70 years

BMC Cancer, 2026

DOI 10.1186/s12885-026-16430-3 PMID 42351034 Açık erişimli tam metinKaynak: OpenAlex

Maintenance pemetrexed after platinum pemetrexed chemotherapy and survival outcomes in malignant pleural mesothelioma in a multicenter real world study

Scientific Reports, 2026

DOI 10.1038/s41598-026-61625-0 PMID 42457832 Açık erişimli tam metinKaynak: OpenAlex

Bevacizumab or Aflibercept in Combination with Second-Line FOLFIRI after Progression on FOLFOX Plus Bevacizumab in Metastatic Colorectal Cancer: A Comparative Study

Journal of Cancer, 2026

DOI 10.7150/jca.138530 PMID 42807710 Açık erişimli tam metinKaynak: OpenAlex

Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group

BMC Cancer, 2026

DOI 10.1186/s12885-026-16667-y PMID 42693417 Açık erişimli tam metinKaynak: OpenAlex

Prognostic significance of pretreatment anemia in patients with advanced cutaneous melanoma

Medical Research Journal, 2026

DOI 10.5603/mrj.110156 Açık erişimli tam metinKaynak: OpenAlex

Prognostic Significance of Systemic Immune Inflammation Index (SII) and Systemic Inflammation Response Index (SIRI) in Patients with Locally Advanced Gastric Cancer Treated with Perioperative FLOT Therapy

Journal of Oncological Sciences, 2026

DOI 10.37047/jos.galenos.2026.2025-12-7 Açık erişimli tam metinKaynak: OpenAlex

The Impact of KRAS Mutation on Treatment Response and Survival in Patients with Metastatic Lung Adenocarcinoma Receiving First-line Systemic Therapy

Journal of Oncological Sciences, 2026

DOI 10.37047/jos.galenos.2026.2026-5-4 Açık erişimli tam metinKaynak: OpenAlex

Distribution of adverse effects of immune checkpoint inhibitors and their impact on survival: some with better but some with worse survival

BMC Cancer, 2026

DOI 10.1186/s12885-026-16954-8 Açık erişimli tam metinKaynak: OpenAlex

The effect of adding ovarian function suppression to adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive, HER2-positive breast cancer who have undergone neoadjuvant therapy: a single-center experience

BMC Cancer, 2026

DOI 10.1186/s12885-026-17017-8 PMID 42786451 Açık erişimli tam metinKaynak: OpenAlex

Clinicopathological Characteristics of Patients with HR-Positive/HER2-Negative Metastatic Breast Cancer Experiencing Early Progression Within 6 Months of CDK4/6 Inhibitor Therapy

Eurasian Journal of Medical Investigation, 2026

DOI 10.14744/ejmi.269433 Kaynak: OpenAlex

Treatment outcomes of sunitinib and/or pazopanib in advanced alveolar soft part sarcoma: A Turkish Oncology Group (TOG) study

Scientific Reports, 2025

DOI 10.1038/s41598-025-29276-9 PMID 41315659 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Factors affecting survival and prognosis in extensive stage small cell lung cancer

BMC Pulmonary Medicine, 2025

DOI 10.1186/s12890-025-03625-w PMID 40200252 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Comparison of clinical and prognostic characteristics of patients with classic and AIDS-related Kaposi sarcoma: A single-center experience

Medicine, 2025

DOI 10.1097/md.0000000000043576 PMID 40760592 Açık erişimli tam metinKaynak: OpenAlex

Distribution of side effects of anti-EGFR treatments in patients with metastatic colorectal cancer and evaluation of their relationship with survival

Anti-Cancer Drugs, 2025

DOI 10.1097/cad.0000000000001755 PMID 40626459 1 atıf (Europe PMC) Kaynak: OpenAlex

Bevacizumab Efficacy and Tolerability in Patients with Metastatic Platinum-Sensitive Ovarian Cancer Beyond Progression

Cancer Management and Research, 2025

DOI 10.2147/cmar.s531276 PMID 40861079 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

The Effect of Total Neoadjuvant Treatment on Pathological Response and Survival in Locally Advanced Rectal Cancer: A Single Center Experience

Clinical Colorectal Cancer, 2025

DOI 10.1016/j.clcc.2025.05.001 PMID 40537334 1 atıf (Europe PMC) Kaynak: OpenAlex

Analysis of the impact of IMDC score parameters on patients with metastatic clear cell renal cell carcinoma

Biomarkers in Medicine, 2025

DOI 10.1080/17520363.2025.2589382 PMID 41243728 Kaynak: OpenAlex

Activation of YAP/TAZ by gut microbiota via Wnt/β-catenin signaling in cancer development

Academia molecular biology and genomics., 2025

DOI 10.20935/acadmolbiogen7642 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Brain metastases during follow-up of patients with resected cutaneous melanoma

Melanoma Research, 2025

DOI 10.1097/cmr.0000000000001026 PMID 39903284 1 atıf (OpenAlex) Kaynak: OpenAlex

Clinical significances of variations in main hematological parameters at the time of diagnosis in patients with small cell lung cancer

Oncology in Clinical Practice, 2025

DOI 10.5603/ocp.108418 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Age-related Survival Declines in Turkish Patients with Cutaneous Melanoma: A Retrospective Analysis

Dermatology Practical & Conceptual, 2025

DOI 10.5826/dpc.1502a4936 PMID 40401870 Açık erişimli tam metinKaynak: OpenAlex

Sex Difference Has No Effect on Survival in Pancreatic Cancer

Indian Journal of Surgical Oncology, 2025

DOI 10.1007/s13193-025-02321-9 PMID 41726035 Açık erişimli tam metinKaynak: OpenAlex

Associations of Increasing Serum Lactate Dehydrogenase Levels With Chemotherapy Responsiveness and Survival in Patients With Extensive Disease Small Cell Lung Cancer

American Journal of Therapeutics, 2025

DOI 10.1097/mjt.0000000000001919 PMID 40965371 Kaynak: OpenAlex

Association of superior vena cava syndrome with small cell lung cancer

Oncology in Clinical Practice, 2025

DOI 10.5603/ocp.108793 Açık erişimli tam metinKaynak: OpenAlex

Evaluation of ixabepilone efficacy and tolerability in metastatic breast cancer

Medicine, 2024

DOI 10.1097/md.0000000000040649 PMID 39809199 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Timing of chemotherapy after diagnosis of small cell lung cancer

Journal of Chemotherapy, 2024

DOI 10.1080/1120009x.2024.2305062 PMID 38250790 2 atıf (Europe PMC) Kaynak: ORCID

Prognostic significance of body mass index and serum albumin as the indicators of nutritional status in small cell lung cancer

Postgraduate Medicine, 2024

DOI 10.1080/00325481.2024.2328512 PMID 38456321 8 atıf (Europe PMC) Kaynak: ORCID

Comorbidity in Small Cell Lung Cancer: Prognostic Impacts of Hypertension/Coronary Artery Disease, Diabetes Mellitus, and Chronic Obstructive Pulmonary Disease

Cancer Investigation, 2024

DOI 10.1080/07357907.2024.2310574 PMID 38299573 10 atıf (OpenAlex) Kaynak: OpenAlex

Female Patients with Small Cell Lung Cancer Have Better Survival than Males with Extensive but Not Limited Disease

Oncology Research and Treatment, 2024

DOI 10.1159/000540244 PMID 38972307 4 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Clinical significances of TTF-1, neuroendocrine (chromogranin, synaptophysin, CD56), and keratin (pancytokeratin, CK7, CK5/6) marker immunostaining in small cell lung cancer

Clinical & Translational Oncology, 2024

DOI 10.1007/s12094-024-03683-2 PMID 39212909 1 atıf (OpenAlex) Kaynak: OpenAlex

A Modified H-index Calculated Using the Duration of Professional Experience and the Author's Significant Contribution to Publications

Cureus, 2024

DOI 10.7759/cureus.53274 PMID 38435880 Açık erişimli tam metinKaynak: OpenAlex

Preliminary outcomes of total (FLOT8) vs standart neoadjuvant (FLOT 4+4) therapy for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma:A propensity-matched comparison

European Journal of Surgical Oncology, 2024

DOI 10.1016/j.ejso.2023.107856 Kaynak: OpenAlex

Primary tumor SUVmax and ratio of SUVmax to primary tumor size on pretreatment 18F-FDG-PET/CT scan in small cell lung cancer

Wiener klinische Wochenschrift, 2023

DOI 10.1007/s00508-023-02160-0 PMID 36882606 7 atıf (OpenAlex) Kaynak: OpenAlex

Melanoma publications do not increase as much as the incidence of melanoma in the last two decades

Journal of Cancer Research and Therapeutics, 2023

DOI 10.4103/jcrt.jcrt_1722_22 PMID 38384070 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Online public interest in smoking and lung cancer: A comparative study in Google Trends

Journal of Cancer Research and Therapeutics, 2023

DOI 10.4103/jcrt.jcrt_276_22 PMID 38384027 4 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Turkey’s contribution to cancer publication: Expected quantity, unsatisfactory quality

Journal of Cancer Research and Therapeutics, 2023

DOI 10.4103/jcrt.jcrt_1291_20 PMID 37148012 Açık erişimli tam metinKaynak: OpenAlex

Ulceration vs. Mitosis in Cutaneous Melanoma: Which Is Superior for Predicting Prognosis Across Clinical Stages?

Cancer Investigation, 2022

DOI 10.1080/07357907.2022.2133139 PMID 36200765 2 atıf (Europe PMC) Kaynak: ORCID

Trunk melanomas: no survival differences between lesion sites

Postgraduate Medicine, 2022

DOI 10.1080/00325481.2022.2080380 PMID 35584552 2 atıf (Europe PMC) Kaynak: ORCID

Limb melanomas: acral melanomas have worse survival

Journal of Dermatological Treatment, 2022

DOI 10.1080/09546634.2021.1877248 PMID 33470132 7 atıf (Europe PMC) Kaynak: ORCID

Major Histotypes in Skin Melanoma: Nodular and Acral Lentiginous Melanomas Are Poor Prognostic Factors for Relapse and Survival

American Journal of Dermatopathology, 2022

DOI 10.1097/dad.0000000000002264 PMID 35925149 18 atıf (OpenAlex) Kaynak: OpenAlex

Cutaneous melanoma survival rates of the elderly are not worse than those of the young, yet they have some specific differences

Journal of Cancer Research and Therapeutics, 2022

DOI 10.4103/jcrt.jcrt_815_21 PMID 37147952 7 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Breast cancer patients are diagnosed at younger ages in Turkey: a comparative study

Irish Journal of Medical Science (1971 -), 2022

DOI 10.1007/s11845-022-03136-1 PMID 35999485 3 atıf (OpenAlex) Kaynak: OpenAlex

Median Age of Cutaneous Melanoma Presentation in Turkey from a Single Tertiary Center Is Younger Than Other Western Countries

Indian Journal of Surgery, 2022

DOI 10.1007/s12262-022-03566-2 1 atıf (OpenAlex) Kaynak: OpenAlex

Neither the presence nor the severity of hyponatremia affected the outcome of the patients with small cell lung cancer

Irish Journal of Medical Science (1971 -), 2022

DOI 10.1007/s11845-022-03199-0 PMID 36279041 1 atıf (OpenAlex) Kaynak: OpenAlex

Seasons Influence Diagnosis of Breast Cancer in Turkey

Indian Journal of Surgery, 2022

DOI 10.1007/s12262-021-03261-8 Kaynak: OpenAlex